Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

PROCEPT BioRobotics (PRCT) Leases (2020 - 2026)

PROCEPT BioRobotics has reported Leases over the past 7 years, most recently at $17.2 million for Q1 2026.

  • Quarterly Leases fell 7.76% to $17.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $17.2 million through Mar 2026, down 7.76% year-over-year, with the annual reading at $17.5 million for FY2025, 7.41% down from the prior year.
  • Leases was $17.2 million for Q1 2026 at PROCEPT BioRobotics, down from $17.5 million in the prior quarter.
  • Over five years, Leases peaked at $24.4 million in Q3 2022 and troughed at $2.5 million in Q2 2022.
  • The 5-year median for Leases is $19.3 million (2024), against an average of $17.9 million.
  • The largest YoY upside for Leases was 775.48% in 2023 against a maximum downside of 15.25% in 2023.
  • A 5-year view of Leases shows it stood at $22.7 million in 2022, then fell by 10.83% to $20.2 million in 2023, then dropped by 6.42% to $18.9 million in 2024, then dropped by 7.41% to $17.5 million in 2025, then dropped by 2.14% to $17.2 million in 2026.
  • Per Business Quant, the three most recent readings for PRCT's Leases are $17.2 million (Q1 2026), $17.5 million (Q4 2025), and $17.9 million (Q3 2025).